VOLUNTARY ANNOUNCEMENT - (1) COMPLETION OF FIRST SUBJECT ENROLLMENT IN PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA; AND (2) UPDATES IN RELATION TO LONG-TERM SAFETY PHASE III CLINICAL TRIAL OF KX-826 FOR THE TREATMENT OF AGA